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Abstract
Background: While the impact of inflammation as the substantial driving force of atherosclerosis has been investigated in
detail throughout the years, the influence of negative regulators of pro-atherogenic pathways on plaque development has
remained largely unknown. Suppressor of cytokine signaling (SOCS)-1 potently restricts transduction of various
inflammatory signals and, thereby modulates T-cell development, macrophage activation and dendritic cell maturation.
Its role in atherogenesis, however has not been elucidated so far.
Methods and Results: Loss of SOCS-1 in the low-density lipoprotein receptor deficient murine model of atherosclerosis
resulted in a complex, systemic and ultimately lethal inflammation with increased generation of Ly-6Chi monocytes and
activated macrophages. Even short-term exposure of these mice to high-cholesterol dieting caused enhanced
atherosclerotic plaque development with accumulation of M1 macrophages, Ly-6C positive cells and neutrophils.
Conclusion: Our data not only imply that SOCS-1 is athero-protective but also emphasize the fundamental, regulatory
importance of SOCS-1 in inflammation-prone organisms.
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Introduction
Atherosclerotic plaque growth and rupture are considered as
the underlying cause of myocardial infarction, sudden cardiac
death and stroke. While the fundamental contribution of
inflammation to atherogenesis has already been extensively
studied, approaches to determine the impact of inhibitors of
inflammatory signaling pathways have remained few so far. [1]
Suppressor of cytokine signalling (SOCS)-1 belongs to a family of 8
intracellular proteins and restricts type I Interferon and Inter-
feron(IFN)-c receptor activation. Thereby, SOCS-1 acts as a
classical negative feedback loop regulator of the Janus kinase and –
signal transducer and activator of transcription (JAK-STAT)
pathway. [2] Furthermore, SOCS-1 restricts toll-like receptor
activation and modulates nuclear factor (NF)-kb dependent
transcription by binding to and induction of degradation of the
p65 subunit. Thereby, SOCS-1 controls innate and adaptive
inflammatory cell behaviour, including macrophages, granulo-
cytes, dendritic cells and T-cells in response to a diverse set of pro-
atherogenic cytokines, e.g. interleukin-6, tumor necrosis factor
(TNF)-a, and IFN-c. [3,4].
SOCS-1 as well as SOCS-3 expression has recently been
demonstrated in murine and human atherosclerotic lesions. In
addition, in vitro studies suggested an anti-inflammatory and
potentially athero-protective effect of these molecules in vascular
cells, e.g. monocytes, endothelial and smooth muscle cells. [5]
While T-cell specific loss of SOCS-3 resulted in reduced plaque
development, the role of SOCS-1 in atherosclerosis has not been
determined yet. [5,6] Therefore, we investigated the impact of a
systemic deficiency of SOCS-1 on atherogenesis in the established,
murine low-density lipoprotein receptor (LDLR) model of
atherosclerosis. We hypothesised that loss of SOCS-1 in this
setting would result in advanced plaque development. In fact, our
data confirm athero-protective features of this molecule but also




Socs-1, Rag-2 deficient animals (B6;129/Sv-Socs1tm1jni-Rag2tm1,
kind gift from J. Ihle, St. Jude Children`s hospital, Memphis, USA)
were crossed with low density lipoprotein receptor (Ldlr)-deficient
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mice (B6.129S7-Ldlrtm1Her/J, Jackson Laboratories, Maine, USA)
to obtain triple knockout (KO) mice (Ldlr2/2;Rag-22/2;Socs-12/
2, hereafter abbreviated as Socs-12/2triple-KO). Ldlr2/2;Rag-
22/2;Socs-1+/+ (Ldlr2/2;Rag-22/2) or Ldlr2/2;Rag-2+/+;Socs-
1+/+ (Ldlr2/2) mice served as controls if not indicated otherwise.
Experiments were performed with male and female mice. No sex-
related differences were observed (data not shown). All mice were
barrier maintained; routine microbiological monitoring according
to FELASA recommendations did not reveal any evidence of
infection with common murine pathogens. This study was
conducted in accordance with the German animal protection
law and with the European Communities Council Directive 86/
609/EEC for the protection of animals used for experimental
purposes. All experiments were approved by the Local Institu-
tional Animal Care and Research Advisory Committee (Institute
for Laboratory Animal Science, Hannover Medical School) and
permitted by the local government (Niedersa¨chsisches Landesamt
fu¨r Verbraucherschutz und Lebensmittelsicherheit). The general
health status of these animals was monitored by daily controls of
physical appearance and determination of an activity score
(1 = lazy, moving slowly; 2 = intermediate; 3 = active moving or
searching for food) as well as weekly controls of body weight.
Animals were killed when signs of weight loss or stagnation
combined with impaired activity were observed. At four weeks of
age, Ldlr2/2, Ldlr2/2;Rag-22/2 and Socs-12/2triple-KO mice
were subjected to a high-cholesterol diet (HCD, (D12108,
Research Diets; 1.25% Cholesterol without cholate, Brogaarden,
Denmark) for 4 weeks or remained on standard chow diet (CD,
AltrominH 1314, Lage, Germany) containing 22.5% protein, 5.0%
fat and 4.5% fibre. Subsequently, mice were euthanized, organs
removed and subjected to further analyses.
Genotyping
The genotype of each mouse was verified by PCR on genomic
DNA (tail tip digest) using the following primers: Ldlr sense: 59-
ACC CCA AGA CGT GCT CCC AGG ATG A-39, Ldlr anti-
sense 59-CGC AGT GCT CCT CAT CTG ACT TGT-39, Rag-
2-1:59-GGG AGG ACA CTC CAC TTG CCA GTA-39, Rag-2-
2:59-AGT CAG GAG TCT CCA TCT CAC TAA-39, Rag-2
neomcyin: 59-CGG CCG GAG AAC CTG CGT GCA A-39,
Socs-1 sense: 59-CAG GCA CCC ACT CCT GGC CTT-39,
Socs-1 anti-sense-1:59-TGG CCA TTC GGC CTG GC CTT-39,
Figure 1. Impact of SOCS-1 deficiency on inflammation and survival. A. Representative picture showing appearance of Socs-12/2triple-KO
mice compared to Ldlr2/2;Rag-22/2;Socs-1+/2 (Socs-1+/2) mice. B. Survival of Socs-12/2 triple-KO mice (N= 22) compared to Ldlr2/2 and Ldlr2/
2;Rag-22/2 animals (N = 40) demonstrating increased mortality of Socs-12/2triple-KO mice C. Representative pictures (HE) of pancreas and lung of
Socs-12/2 triple-KO mice compared to Socs-1+/2 animals demonstrating increased, diffuse infiltration of mixed inflammatory cells (lymphocyte-like
cells, and neutrophils) in both organs (scale bar 100 mm). D. Representative pictures (HE) of colon showing typhlitis in Socs-12/2 triple-KO mice
compared to Ldlr2/2animals. E. Representative pictures of aortic roots derived from Ldlr2/2, Ldlr2/2;Rag-22/2 and Socs-12/2 triple-KO mice showing
comparable macrophage infiltration without formation of atherosclerotic plaques under chow diet (scale bar: 50 mm).
doi:10.1371/journal.pone.0051608.g001
SOCS-1 and Atherosclerosis
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Socs-1 anti-sense-2:59-GCC TTC TTG ACG AGT TCT TCT
G-39.
Aortic Lipid Deposition
For the analysis of aortic lipid depositions, aortas were prepared
en face and stained with Oil Red O solution as previously
described. [7] Percentage of Oil Red O positive area was
calculated via computer-assisted image quantification (Leica Qwin
500, Leica, Heidelberg, Germany).
Atherosclerotic Plaque Analysis
To analyse atherosclerotic plaque area and composition, aortic
roots were embedded in Tissue-TekH O.C.TTM and kept at
280uC until sectioning. Within the aortic root, lesion area was
analyzed in cross sections obtained at the level of all three leaflets
of the aortic valve after staining with Oil Red O solution as
previously described. [8] Serial cross sections (5 mm) were
collected, 6–9 sections/animals were analysed via computer-
assisted image quantification (Leica Qwin 500, Leica, Heidelberg,
Germany). Neutrophils were identified using a rat anti-mouse Ly-
6G antibody (clone IA8, BD Bioscience, San Jose, USA).
Monocytes/macrophages were detected with a rat anti-mouse
MOMA-2 antibody (Acris, Herford, Germany), the biotinylated
secondary antibody (rabbit anti-rat) was visualized by ABC
reagent (Vector Laboratories, Burlingame, USA) and the AEC-
Chromogen (DAKO, Glostrup, Denmark) according to the
manufacturer’s protocol. Sections were counterstained with
hematoxylin (Carl Roth, Karlsruhe, Germany). For visualisation
of Ly-6C/MOMA-2 double positive cells, sections were incubated
with biotinylated anti-mouse Ly-6C antibody (AL-21, BD
Pharmingen, Franklin Lakes, USA) and rat anti-mouse MOMA-
2 followed by visualization using streptavidin-Fitc and anti-rat
Alexa-549 (Invitrogen, Molecular Probes, Darmstadt, Germany).
For staining of CD68/iNOS and CD68/CD206 double-positive
cells, we followed a protocol published by Salagianni et al. [9] In
short, sections were incubated with rat anti-mouse CD68 (clone
FA-11, AbD serotec, Oxford, UK) and rabbit anti-mouse iNOS
(AbCam, Cambridge, UK) or rabbit anti-mouse CD206 (clone
MR5D3, AbD serotec, Oxford, UK) or respective isotype controls
followed by incubation with anti-rat Alexa-549 or anti-rabbit
Alexa-488 (both Invitrogen, Molecular Probes, Darmstadt,
Germany). Nuclei were counterstained with DAPI (Invitrogen,
Molecular Probes, Darmstadt, Germany).






Weight of mice on chow (CD) and after high-cholesterol diet (HCD).
Age-matched mice were weighted after 4 weeks of CD or HCD. Socs-12/2 triple
KO mice (Socs-12/2) on CD and HCD demonstrated a significantly lower weight
compared to Ldlr2/2 and Ldlr2/2;Rag-22/2 mice. However, Socs-12/2triple-KO
mice displayed a significant weight gain after 4 weeks of HCD compared to
Socs-12/2triple-KO mice on CD. Data represent mean6SD, *p,0.05 vs Ldlr2/2
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Histological Analysis
Paraffin embedded, serial sections from various organs were
subjected to hematoxylin/eosin (HE) staining. In short, nuclei
were stained with alum hematoxylin and differentiated with acid
alcohol followed by staining with eosin solution. For Sirius Red
staining, we followed a protocol published elsewhere. [10] In short,
sections were stained with Sirius Red solution (0.1% Sirius Red in
saturated picric acid solution). Section analysis was carried out
using polarization microscopy.
Plasma Analysis
Systemic Tumor necrosis factor (TNF)-a, Interleukin (IL)-6 and
MCP (monocyte chemotactic protein)-1 levels were measured
using ELISA (all from R&D Systems, Minneapolis, USA)
following the manufacturer`s protocol.
Lipoprotein Fraction Analysis
The concentration of total cholesterol and triglycerides in
plasma was determined using enzymatic colorimetric assays
(Roche Diagnostics, Grenzach, Germany). The distribution of
cholesterol over the different lipoprotein subclasses in plasma was
determined in two different ways. Fast protein liquid chromatog-
raphy (FPLC) of 100 mL of pooled plasma samples from the
respective experimental groups using a Superose 6 column (LKB
Biotechnology, Uppsala, Sweden) was carried out as described
Figure 2. SOCS-1 deficiency results in enhanced levels of pro-inflammatory cytokines. A. Socs-12/2 triple-KO mice (Socs-12/2) showed
significantly enhanced circulating TNF-a levels after 4 weeks of CD and HCD while no change was found in Ldlr2/2 and Ldlr2/2;Rag-22/2mice. B and
C. Socs-12/2triple-KO mice (Socs-12/2) showed significantly enhanced levels of MCP-1 (B) and IL-6 (C) on CD while 4 weeks of HCD did not induce an
additional increase in these mice. MCP-1 and IL-6 levels were significantly increased in Ldlr2/2 and Ldlr2/2;Rag-22/2mice on HCD. *p,0.05 vs Ldlr2/2
and Ldlr2/2;Rag-22/2 on HCD, #p,0.05 vs Ldlr2/2 and Ldlr2/2;Rag-22/2 on CD, N= 7 samples/group.
doi:10.1371/journal.pone.0051608.g002
Table 3. Cholesterol Levels after 4 Weeks of High-Cholesterol
Diet.
Cholesterol
levels (mg/dl) Ldlr2/2 Ldlr2/2;Rag-22/2 Socs-12/2triple-KO
TC 1108 702* 1018
LDL 331 210* 296
VLDL 619 351* 515
HDL 155 142 161
Cholesterol levels after 4 weeks of high-cholesterol diet (HCD). No
differences in lipoprotein fractions between age-matched Ldlr2/2 and Socs-12/
2triple-KO mice were observed after 4 weeks of HCD. Total cholesterol levels
were significantly lower in Ldlr2/2;Rag-22/2 mice compared to the other
genotypes due to lower LDL and VLDL lipoprotein fractions. *p,0.05 vs Ldlr2/2
and Socs-12/2triple-KO mice, data are mean 6 SD, N = 7–10 mice/group.
doi:10.1371/journal.pone.0051608.t003
SOCS-1 and Atherosclerosis
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previously. [11] In addition, sequential tabletop ultracentrifuga-
tion was performed to separate VLDL, LDL and HDL as
published. [11] Total cholesterol content in the respective fractions
was determined using enzymatic colorimetric assays (Roche
Diagnostics, Grenzach, Germany).
LDL-Isolation and Peroxidation
For in-vitro experiments, LDL was isolated from human plasma
by sequential gradient ultracentrifugation. [12] LDL fraction was
dialyzed at 4uC against phosphate buffer (140 mM NaCl,
1.9 mM NaH2HPO4, 8.1 mM). Protein concentration was deter-
mined by the Bradford method. For peroxidation, native (n)LDL
(100 mg/mL) was incubated with CuSO4 (10 mmol/L) in cell
culture medium for 24 hrs. LDL-peroxidation was stopped with
EDTA (5 mmol/L) and butylhydroxytoluol (20 mmol/L). LDL-
peroxidation was analyzed by detection of conjugated diene
formation by measuring UV absorbance at 234 nm. [13]
Additionally malondialdehyde as lipid peroxidation product was
measured using the thiobarbituric acid-reactive assay (TBARS
assay kit, Oxitech, Buffalo, USA).
Generation of Bone-Marrow Derived Macrophages
To generate macrophages, bone marrow cells (BMC) were
isolated and cultivated in RPMI 1640 (GIBCO/Invitrogen
Darmstadt, Germany), supplemented with 10% fetal calf serum
(FCS) +1% penicillin/streptomycin and 20% L929 conditioned
medium for 7 days as previously described. [14].
In Vitro Foam Cell Formation
BMC were differentiated into bone-marrow derived macro-
phages (BMDM) as described above. In-vitro foam cell formation
was induced by incubating BMDM with 25 mg/mL oxidized
(ox)LDL and nLDL for 4 hrs. After stimulation, cells were washed
twice with PBS, fixated in 3.7% paraformaldehyde followed by
staining of intracellular lipids with Oil red O for 30 min. The
percentage of Oil red O positive stained cells was quantified by
Figure 3. SOCS-1 deficiency results in enhanced atherosclerotic plaque formation. A. Aortas derived from Socs-12/2 triple-KO mice (Socs-
12/2) showed significantly enhanced lipid depositions after en face preparation and staining with Oil Red O after 4 weeks of HCD. B. Aortic roots of
Socs-12/2 triple-KO mice also displayed increased lipid depositions after staining with Oil Red O. Horizontal bars represent mean, *p,0.05 vs Ldlr2/2
and Ldlr2/2;Rag-22/2 (scale bar: 50 mm). Each dot indicates results for an individual animal. C. Aortic roots derived from Socs-12/2 triple-KO (Socs-12/
2) mice showed a significantly enhanced macrophage content after staining with MOMA-2 compared to Ldlr2/2;Rag-22/2 and Ldlr2/2 mice after 4
weeks of HCD. Horizontal bars are mean, *p,0.05 vs Ldlr2/2 and Ldlr2/2;Rag-22/2. Each dot indicates results for an individual animal. (scale bar:
500 mm). D. Phenotype analysis of atherosclerotic plaques demonstrated more advanced lesion development in Socs-12/2triple-KO (Socs-12/2) mice.
N = 5–8 mice/group.
doi:10.1371/journal.pone.0051608.g003
SOCS-1 and Atherosclerosis
PLOS ONE | www.plosone.org 5 December 2012 | Volume 7 | Issue 12 | e51608
randomly choosing 5 microscopic fields using computer-assisted
image analysis (Axiovert 200 M). [15].
Scavenger Receptor A and CD36 Expression
BMDM were stimulated with oxLDL or nLDL for 24 hrs
followed by double-staining of scavenger receptor (SR) A (anti-
mouse CD204-Alexa-Fluor 647, AbD Serotec, Oxford, UK) and
CD36 (anti-mouse CD36-PE, eBioscience, San Diego, USA) or
the respective isotype controls. Unspecific binding of antibodies to
Fc receptors was reduced by pre-incubation of BMDM with
CD16/32 (anti-mouse CD16/CD32, eBioscience). Expression was
analysed by flow cytometry (FACSCalibur, Becton, Dickinson and
Company, Franklin Lakes, USA).
Cell Sorting
Cells were harvested from bone marrow, peripheral blood and
spleens as described by Swirski et al. [16] BMCs from both tibias
and femurs were harvested. Peripheral blood was drawn via
cardiac puncture and collected into EDTA tubes. Mononuclear
cells were purified by density centrifugation. Differential blood
counts were obtained using the Vet abc Animal Blood Counter
(scil animal care company GmbH, Viernheim, Germany). Spleens
were removed and filtered through a nylon mesh (BD Bioscience).
The cell suspensions were centrifuged, red blood cells were lysed
with NH4Cl (0.155 M), and the resulting single-cell suspensions
were washed with PBS supplemented with 0.2% EDTA and 2%
FCS. Cells were incubated with a cocktail of monoclonal
antibodies against T cells (anti CD90-PE, clone 53–2.1, BD
Bioscience), B cells (anti CD45R-PE, B220, clone RA3-6B2,
eBioscience), NK cells (anti CD49b-PE, clone DX5, eBioscience
and NK1.1-PE, clone PK136, BD Bioscience), granulocytes (anti
Ly-6G–PE, clone 1A8, BD Bioscience), myeloid cells (anti CD11b-
APC, clone M1/70, eBioscience) and monocyte subsets (anti Ly-
6C–FITC, clone AL-21, BD Bioscience). Monocytes were
identified as CD11bhi (CD90, B220, CD49b, NK1.1, Ly-
6G)locells. Macrophage marker F4/80-PE (ebioscience), the
MHC class II anti-I-Ab-PE (BD Bioscience), and CD11c-PE
(eBioscience) mAbs were additionally used to identify CD11bhi
(CD90, B220, CD49b, NK1.1, Ly-6G, F4/80, CD11c, I-AB)lo
cells in spleens. Monocyte subsets were further identified as either
Ly-6Chi or Ly-6Clo.
Statistical Analysis
Data are presented as mean and standard error of mean (SEM)
or standard deviation (SD). Statistical analyses were performed
using SigmaStat 3.0 (SyStat, San Jose, USA). Comparisons
between two groups were performed by Student’s t-test assuming
two-tailed distribution and equal variances. One-way ANOVA
was used for the comparisons between three groups. For unequal
group sizes with failed normality tests, Rank-based ANOVA was
used and data presented as median with 25th and 75th percentile. P
values ,0.05 were considered statistically significant.
Figure 4. Impact SOCS-1 deficiency on monocyte formation under chow diet (CD). A-C. Peripheral blood (A), bone-marrow (B) and spleen
(C) of age-matched mice from all three genotypes under CD were subjected to cell sorting. Monocytes were determined as CD11bhi (CD90, B220,
CD49b, NK1.1, Ly-6G)lo cells. Triple-KO (Socs-12/2) mice showed significantly enhanced numbers of circulating CD11b+ cells. D-F. Monocytosis was
mainly due to an increase of the Ly-6Chi subset. Horizontal bars represent mean. *p,0.05 vs Ldlr2/2;Rag-22/2 and Ldlr2/2mice. Each dot represents
the results for an individual animal of an independent experiment.
doi:10.1371/journal.pone.0051608.g004
SOCS-1 and Atherosclerosis
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Results
Deficiency of SOCS-1 in Atherosclerosis-prone Mice
Results in a Lethal, Systemic Inflammation
To assess the impact of SOCS-1 deficiency on atherogenesis,
Ldlr+/+;Rag-22/2;Socs-12/2 (Rag-22/2;Socs-12/2) mice were
crossed with Ldlr2/2;Rag-2+/+;Socs-1+/+ (Ldlr2/2) mice to
generate Ldlr2/2;Rag-22/2;Socs-12/2 (Socs-12/2 triple-KO)
mice. The necessity of combining a systemic lack of SOCS-1
with a RAG-2 deficiency is due to the fact that Socs-12/2 mice
suffer from a severe hypersensitivity towards IFN-c signaling that
leads to death within 3 weeks after birth. Lack of RAG-2, however
results in depletion of lymphocytes, a major source for IFN-c.
Accordingly, Rag-22/2;Socs-12/2 mice have been demonstrated
to survive until adulthood. [17].
Socs-12/2 triple-KO mice exhibited lower weight gain and
growth retardation (table 1 and figure 1A) and died within 120
days after birth (figure 1B). Every other documented genotype
appeared to be healthy including heterozygous Ldlr2/2;Rag-22/
2;Socs-1+/2 mice. Histological analysis by HE staining of organs
derived from Socs-12/2triple-KO mice showed a systemic
inflammation with multi-organ infiltration of mixed inflammatory
cells (figure 1C) as well as signs of colitis (figure 1D). Atheroscle-
rotic plaque development in aortic roots was not detected under
CD (figure 1E). As demonstrated by differential blood counts,
Ldlr2/2;Rag-22/2 and Socs-12/2triple-KO mice displayed a
significant leucopenia that was compensated in Socs-12/2triple-
KO mice by granulocytosis, resulting in similar total circulating
leukocyte numbers compared to Ldlr2/2 mice. Granulocytosis
was mainly due to neutrophilia (table 2). However, while
Geissmann et al reported that RAG-2 dependent lymphopenia
may be compensated by monocytosis, RAG-2 deficiency in
combination with lack of the LDLR did not affect monocyte
proportions. [18] Apart from the severely impaired life span,
generation of Socs-12/2 triple-KO mice resulted in a phenotype
resembling characteristics of both, Rag-22/2;Socs-12/2 and Socs-
12/2 animals. [19] Ldlr2/2;Rag-22/2 mice, though were
indistinguishable from Ldlr2/2 animals.
Systemic Deficiency of SOCS-1 Accelerates Early
Atherogenesis
To investigate the impact of SOCS-1 on early atherogenesis, we
fed Ldlr2/2; Ldlr2/2;Rag-22/2 and Socs-12/2 triple-KO mice a
high-cholesterol diet (HCD) for 4 weeks. To contain any possibly
confounding impact of deteriorating organ function in Socs-
12/triple-KO mice, HCD was started directly after weaning at the
age of 30–40 days.
Despite a significant weight gain, Socs-12/2 triple-KO mice
remained lighter compared to the other genotypes after 4 weeks
of HCD (table 1). Lipoprotein fractions did not differ between
Socs-12/2 triple-KO and Ldlr2/2 mice. However, Ldlr2/
2;Rag-22/2 mice displayed decreased total cholesterol levels
caused by a lower LDL- and VLDL-cholesterol fraction (table 3).
Analysis of plasma samples revealed significantly increased
Figure 5. Impact SOCS-1 deficiency on monocyte formation under high-cholesterol diet (HCD). Peripheral blood, bone-marrow and
spleen of age-matched mice from all three genotypes after 4 weeks of HCD were subjected to cell sorting. While cell numbers of CD11b+; Ly-6Chi
monocytes remained significantly higher in bone-marrow and spleen of Socs-12/2 triple-KO (Socs-12/2) mice, circulating CD11b+; Ly-6Chi monocyte
numbers decreased. Horizontal bars represent mean. *p,0.05 vs Ldlr2/2;Rag-22/2 and Ldlr2/2 mice. Each dot represents the results for an individual
animal of an independent experiment.
doi:10.1371/journal.pone.0051608.g005
SOCS-1 and Atherosclerosis
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circulating monocyte chemotactic protein (MCP)-1 and inter-
leukin (IL)-6 levels in Ldlr2/2 and Ldlr2/2;Rag-22/2 mice
after HCD while tumor necrosis factor (TNF)-a levels remained
unchanged. Socs-12/2triple-KO mice however showed in-
creased levels of all three chemokines/cytokines already under
CD while 4 weeks of HCD did not induce any further increase
(figure 2A–C).
The extent of atherosclerotic plaque development was
analysed in complete aortas prepared en face and stained with
Oil Red O and demonstrated significantly enhanced lipid
depositions in vessels of Socs-12/2triple-KO mice (figure 3A).
Concomitantly, we also observed increased atherosclerotic lesion
formation (figure 3B) and an accumulation of macrophages
(MOMA-2 positive cells) in aortic roots of Socs-12/2triple-KO
mice (figure 3C). Atherosclerotic plaque progression was
analysed using the recommendations of the report from the
Committee on Vascular Lesions of the Council on Arterioscle-
rosis, American Heart Association (figure 3D). [20] Overall,
very early lesions types dominated after 4 weeks of HCD
regardless of the respective genotype. However, plaques
obtained from Socs-12/2 triple-KO mice proved to be the
most advanced. To further characterize lesion composition we
performed Sirius Red stainings but did not observe any
significant extracellular matrix formation after 4 weeks of
high-cholesterol dieting (figure S2A).
SOCS-1 Regulates Monocyte Ly-6Chi Subset Formation in
Atherosclerosis-prone Mice
Cell sorting experiments were performed in age-matched mice
after 4 weeks of chow diet (CD) or high-cholesterol diet (HCD).
Despite the overall leukopenia of Socs-12/2triple-KO mice under
CD, flow cytometric analysis of blood samples (figure S1)
demonstrated a marked increase in circulating CD11bhi mono-
cytes (figure 4A) that was mainly due to an increase of the Ly-6Chi
cell subset (figure 4D). Similar observations were made in bone-
marrow (figure 4B and E) and spleens of Socs-12/triple-KO mice
(figure 4C and F). Analysis of the Ly-6Clo subset revealed no
differences between triple-KO mice and Ldlr2/2 mice, but
significantly less circulating Ly-6Clo cells in Ldlr2/2;Rag-22/2
mice (data not shown).
4 weeks of HCD resulted in a significant rise of total circulating
leukocytes in Ldlr2/and Ldlr2/2;Rag-22/2 mice compared to
mice on CD (table 2). However, we observed a tendency toward
decreased numbers of leukocytes and granulocytes in peripheral
blood of Socs-12/2triple-KO mice (table 2). Analysis of leukocyte
subsets indicated a slight, but not statistically significant rise of
Figure 6. Impact of SOCS-1 deficiency on atherosclerotic plaque composition A. Atherosclerotic plaques from Socs-12/2 triple-KO (Socs-
12/2) mice showed an increased CD68 (red);iNOS (green) double-positive cell content. B. CD68 (red); CD206 (green) double-positive cells were hardly
detected. C. Atherosclerotic plaques from Socs-12/2triple-KO (Socs-12/2) mice contained slightly more MOMA-2 (red); Ly-6C (green) double-positive
cells after 4 weeks of HCD as well as D. a higher number of Ly-6G positive cells (scale bar A–C: 20 mm, scale bar D:50 mm). N= 5–7 animals per group.
doi:10.1371/journal.pone.0051608.g006
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CD11bhi monocytes and Ly-6Chi cells in peripheral blood of
Ldlr2/2 and Ldlr2/2;Rag-22/2 animals. In Socs-12/2 triple-KO
mice the proportion of circulating CD11bhi monocytes and Ly-
6Chi cells decreased (figure 5A and D) while Ly-6Chi monocytosis
persisted in bone-marrow (figure 5B and E) and spleens (figure 5C
and F). Numbers of Ly-6Clo monocytes did not significantly
change under HCD with regard to genotype or hematopoietic
compartment (data not shown).
Considering the contribution of Ly-6Chi monocytes to athero-
sclerotic plaque formation together with the sustained generation
of these cells in bone-marrow and spleens of Socs-12/2 triple-KO
mice, we hypothesized, that the reduced number of circulating
monocytes after 4 weeks of HCD might reflect an increased cell
extravasation with subsequently enhanced lesion development at
this particular point of time. Therefore, we performed double
stainings of MOMA-2 and Ly-6C in atherosclerotic plaques
Figure 7. Impact of SOCS-1 deficiency on scavenger receptor CD36 expression and foam cell formation under chow diet (CD) and
high-cholesterol diet (HCD). A and B. Representative histograms of CD36 expression of bone-marrow derived macrophages (BMDM) obtained
from all 3 genotypes after 4 weeks of CD of HCD. C and D. BMDM of triple-KO mice (Socs-12/2) displayed a significantly enhanced CD36 expression
determined by flow cytometry under CD. Under HCD, CD36 expression further increased on Socs-12/2 BMDM. E. BMDM from Socs-12/2 mice
showed significantly enhanced foam cell formation determined after stimulation with oxLDL after 4 weeks of CD. F. Under HCD foam cell formation
did not differ between the genotypes anymore. Data are mean6SEM, *p,0.05 vs Ldlr2/2 and Ldlr2/2;Rag-22/2, N = 5–13 mice/group.
doi:10.1371/journal.pone.0051608.g007
SOCS-1 and Atherosclerosis
PLOS ONE | www.plosone.org 9 December 2012 | Volume 7 | Issue 12 | e51608
obtained from Socs-12/2 triple-KO mice. While the overall
number of double-positive cells proved to be quite low and was
constricted to small, very early lesions, these stainings indicated an
enhanced number of MOMA-2/Ly-6C positive cells in Socs-12/
2triple-KO mice although these observations did not reach
statistical significance (figure 6C). Given the neutrophilia in
Socs-12/2triple-KO mice, we also stained aortic roots for Ly-
6G as a marker for neutrophils. Again, the total cell number
detected was very low. However, quantitative analysis revealed
increased lesion infiltration of Ly-6G positive cells in Socs-12/
2triple-KO mice (figure 6D).
SOCS-1 Regulates Pro-atherogenic Macrophage
Formation in Atherosclerosis-prone Mice
To further investigate the impact of SOCS-1 on macrophage
phenotype in atherogenesis, scavenger receptor (SR)-A and CD36
expression were determined on bone-marrow derived macrophag-
es (BMDM) after CD and HCD. While SR-A expression did not
differ between the genotypes (data not shown), macrophages
received from Socs-12/2triple-KO mice on CD already showed a
significantly enhanced expression of CD36 compared to Ldlr2/
2;Rag-22/2 or Ldlr2/2 mice that further increased after HCD
(figure 7A–D). Subsequently, stimulation with oxLDL resulted in a
markedly higher proportion of foam cell formation in SOCS-1
deficient BMDM compared to BMDM derived from Ldlr2/
2;Rag-22/2 and Ldlr2/2 mice on chow diet that did not further
increase after HCD (figure 7E–F). Given these findings, we also
analysed intra-plaque macrophage phenotypes. In this regard, we
performed double stainings using CD68 in combination with
iNOS for detection of M1 macrophages (figure 6A) versus CD68
combined with CD206 for tracking of M2 macrophages (figure 6B).
While we hardly detected any M2 macrophages regardless of the
respective genotype, Socs-12/2 triple-KO mice showed an
enhanced proportion of M1 macrophages although it did not
reach statistical significance due to the low overall cell number.
Discussion
Atherosclerosis is a chronic inflammatory disease of the arterial
cardiovascular system. [21] As SOCS-1 has been demonstrated to
restrict the activation of various pro-atherogenic pathways, [2] we
postulated that loss of SOCS-1 in an atherosclerosis-prone
organism might aggravate plaque development.
To address this question, we generated Ldlr2/2;Rag-22/
2;Socs-12/2triple-KO mice. These animals suffered from a
complex systemic inflammation with familiar features of Rag-
22/2;Socs-12/2 and Socs-12/2 mice, including leucopenia and
neutrophilia. Beyond that, the additional lack of the LDLR in
Socs-12/2 triple-KO mice resulted in a Ly-6Chi cell-dependent
monocytosis.
Ly-6Chi monocytes are defined as a short-lived Cx3CR
lo cell
subset that drives inflammation by extravasation, tissue infiltration
and differentiation into phagocytes. In context with atherogenesis,
they are considered as the major, pro-atherogenic monocyte
population. [22] So far, data discussing the impact of SOCS-1 on
monocyte generation or function has been limited to experimental
settings of infection. [23] For example, human monocytes have
been shown to up-regulate SOCS-1 in response to nitric oxide
resulting in reduced secretion of IL-6 and IL-10. [24] In addition,
increased SOCS-1 expression in monocytes infected with hepatitis
C aggravates disease activity by modulating IL-12 secretion while
in Ly-6Chi monocytes isolated from bone-marrow of C57BL/6
mice infected with Listeria monocytogenesis early SOCS-1
expression is associated with host outcome. [25,26].
As mentioned above, Ly-6Chi monocytes are regarded as a vital
source for plaque macrophages. These phagocytes undergo foam
cell formation by up-take of oxidized LDL particles via scavenger
receptors - a dominating event in early lesion development.
Interestingly, macrophages derived from Socs-12/2triple-KO
mice on chow diet already displayed significantly enhanced
scavenger receptor CD36 expression. Accordingly, we also found
a profoundly increased foam cell formation of these cells ex vivo.
Spontaneous atherogenesis is scarce in Ldlr2/2 mice. Never-
theless, given the increased generation of Ly-6Chi monocytes and
activated macrophages together with the enhanced circulating
levels of IL-6, TNF-a and MCP-1, we speculated that atheroscle-
rotic plaque development might already occur in SOCS-12/
2triple-KO mice on chow diet. However, we did not observe
lesion formation in the absence of hypercholesterolemia regardless
of the genotype investigated.
Thus, we subjected Ldlr2/2, Ldlr2/2;Rag-22/2 and Socs-12/
2 triple-KO animals to 4 weeks of HCD starting directly after
weaning.
While lipoprotein fractions did not significantly differ between
Ldlr2/2 and Socs-12/2 deficient mice after the feeding period,
they proved to be slightly lower in Ldlr2/2;Rag-22/2 animals.
These results are consistent with the observations of other groups
investigating the impact of RAG-2 deficiency in the ApoE mouse
model of atherosclerosis. Neither we nor previous studies have
been able to elucidate the underlying mechanisms. However,
regarding the importance of lymphocytes for barrier-functions –
including the gastro-intestinal tract – one might speculate that
lymphocyte depletion may disturb both, lipoprotein up-take as
well as transport. [27,28].
Despite the short period of HCD and the young age of animals,
we found enhanced atherosclerotic lesion formation throughout
the aorta as well as in aortic roots of Socs-12/2triple-KO mice.
Accordingly, investigation of plaque composition revealed an
increased content of macrophages with pro-atherogenic M1
features in these mice. SOCS-1 is a known modulator of
macrophage activation by suppressing CD40, IL-6 and TNF-a
expression. [29,30] Furthermore, as shown by Whyte et al. in
context with parasite infection, SOCS-1 may confine classically
activated M1 macrophage formation and foster alternatively
activated - potentially anti-atherogenic - M2 macrophage gener-
ation. [3] Thus, these observations support the pro-atherogenic
impact of SOCS-1 deficiency in this mouse model. The fact that
we hardly detected any M2 macrophages regardless of the
genotype examined may reflect the mainly pro-inflammatory
sub-intimal environment at this particular time of plaque
development. [31].
Overall, lesion phenotype analysis confirmed that atherogenesis
proved to be the most advanced in Socs-12/2triple-KO mice.
Flow cytometric analysis of peripheral blood demonstrated
markedly decreased numbers of CD11b+;Ly-6Chi monocytes in
Socs-12/2 triple-KO mice after 4 weeks of HCD, while these cells
remained increased in bone-marrow and spleen. We hypothesized,
that the reduced number of circulating monocytes in Socs-12/
2triple-KO mice might have reflected an increase in vascular
extravasation. [29] We resigned from performing sorting exper-
iments with SOCS-1 deficient aortic tissue due to the short feeding
period, the young age of mice and the overall low circulating
CD11b+;Ly-6Chi cell number. Instead, we stained aortic roots for
MOMA-2, Ly-6C double-positive cells. Although the fate of Ly-
6Chi monocytes after entering the sub-intimal space likely depends
on the local cytokine/chemokine balance at the particular time of
entrance and thus, may change during plaque development, we
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detected more MOMA-2, Ly-6C double-positive cells in develop-
ing Socs-12/2triple-KO lesions.
Given the systemic neutrophilia observed in SOCS-1 deficient
animals, we also examined atherosclerotic plaques for neutrophil
infiltration. Indeed, we found more Ly-6G positive cells in lesions
derived from Socs-12/2triple-KO mice. Neutrophils have recently
gained attention and may particularly contribute to early
atherogenesis by production of oxygen radicals and secretion of
pro-inflammatory granules. [32] Therefore, neutrophils may be
involved in the atherogenic phenotype of SOCS-1 deficient mice
in this study.
We are also aware of the fact, that disturbed T- and B-cell
development caused by loss of RAG-2 might have influenced
atherogenesis in this mouse model especially since RAG-2
deficiency obviously modulated lipoprotein homeostasis. In this
context Reardon et al found a close correlation between
lipoprotein levels and lesion extent in Rag-22/2;ApoE2/2 mice
as well as a site-specific difference in plaque development.
However, others did not detect any obvious effects of RAG-2 on
lesion size. [27,28] In the study presented, we did not observe
significant differences in plaque development between Ldlr2/2
and Ldl2/2;Rag-22/2 mice despite a tendency towards more
advanced lesions in Ldlr2/2;Rag-22/2 animals. These results
surely do not negate the impact of lymphocytes on atherogenesis.
Instead they may rather be a consequence of this specific study
design with very young mice undergoing a short feeding period.
One might also argue that the atherogenic phenotype of Socs-
12/2triple-KO animals may be secondary to the ongoing systemic
inflammation and therefore, of constricted biological relevance.
However, we did not find atherosclerotic plaque formation in
Socs-12/2 triple-KO mice until induction of hypercholesterolemia
despite Ly-6Chi monocytosis, activation of macrophages and
neutrophilia under chow diet conditions indicating that a specific,
pro-atherogenic trigger was necessary for induction of plaque
development. Furthermore, deletion of a single SOCS-1 allele
resulted in effects similar to those observed in Socs-12/2triple-KO
animals (figure S2B–D). In summary, this study demonstrates the
athero-protective nature of SOCS-1 in experimental, murine
atherosclerosis.
Supporting Information
Figure S1 Cell sorting of blood derived from Ldlr2/2,
Ldlr2/2;Rag-22/2 and Ldlr2/2;Rag-22/2;Socs-12/2. A
and B. Representative dot plots showing cell sorting of CD11bhi
(CD90, B220, CD49b, NK1.1, Ly-6G)lo cells from blood derived
from all three, age-matched genotypes after (A) 4 weeks of chow
diet (CD) or (B) 4 weeks of high-cholesterol diet (HCD). C and D.
Representative histograms demonstrating the proportion of Ly-
6Chi blood monocytes among CD11bhi (CD90, B220, CD49b,
NK1.1, Ly-6G)lo cells in all three genotypes. Independent cell
sorting experiments were performed in specimens derived from 8–
17 animals per group.
(TIF)
Figure S2 Impact of SOCS-1 on extracellular matrix
formation and Impact of SOCS-1+/2 on atherosclerotic
plaque development and plaque content of macrophages
after 4 weeks of high-cholesterol diet (HCD). A. Repre-
sentative pictures demonstrating that atherosclerotic plaque
development did not involve significant collagen formation after
4 weeks of HCD regardless of the genotype investigated B. Aortas
derived from Socs-1+/2 mice showed significantly enhanced lipid
depositions after en face preparation and staining with Oil Red O
after 4 weeks of HCD. Results were comparable to those derived
from Socs-12/2triple-KO mice C and D. Aortic roots of Socs-1+/
2 mice also displayed increased macrophage content after staining
with MOMA-2 (C) and enhanced lipid depositions after staining
with Oil Red O (D) after 4 weeks of HCD. Both results were
comparable to those derived from Socs-12/2 triple-KO mice.
Horizontal bars represent mean, *p,0.05 vs Ldlr2/2 and Ldlr2/
2;Rag-22/2 (C: scale bar: 500 mm, D: scale bar: 50 mm). Each
dot indicates results for an individual animal.
(TIF)
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